| Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children S Black, H Shinefield, B Fireman, E Lewis, P Ray, JR Hansen, L Elvin, ... The Pediatric infectious disease journal 19 (3), 187-195, 2000 | 2799 | 2000 |
| Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia SB Black, HR Shinefield, S Ling, J Hansen, B Fireman, D Spring, J Noyes, ... The Pediatric infectious disease journal 21 (9), 810-815, 2002 | 735 | 2002 |
| Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente S Black, H Shinefield, R Baxter, R Austrian, L Bracken, J Hansen, E Lewis, ... The Pediatric infectious disease journal 23 (6), 485-489, 2004 | 449 | 2004 |
| Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine SB Black, HR Shinefield, J Hansen, L Elvin, D Laufer, F Malinoski The Pediatric infectious disease journal 20 (12), 1105-1107, 2001 | 351 | 2001 |
| Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers HR Shinefield, S Black, P Ray, IH Chang, NED Lewis, B FIREMAN, ... The Pediatric infectious disease journal 18 (9), 757-763, 1999 | 349 | 1999 |
| Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health … J Hansen, S Black, H Shinefield, T Cherian, J Benson, B Fireman, E Lewis, ... The Pediatric infectious disease journal 25 (9), 779-781, 2006 | 321 | 2006 |
| Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine C Chao, NP Klein, CM Velicer, LS Sy, JM Slezak, H Takhar, B Ackerson, ... Journal of internal medicine 271 (2), 193-203, 2012 | 271 | 2012 |
| Acute intussusception in infants and children as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation JE Bines, KS Kohl, J Forster, LR Zanardi, RL Davis, J Hansen, TM Murphy, ... Vaccine 22 (5), 569, 2004 | 260 | 2004 |
| Changing epidemiology of outpatient bacteremia in 3-to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine AM Herz, TL Greenhow, J Alcantara, J Hansen, RP Baxter, SB Black, ... The Pediatric infectious disease journal 25 (4), 293-300, 2006 | 257 | 2006 |
| Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents R Bergen, S Black, H Shinefield, E Lewis, P Ray, J Hansen, R Walker, ... The Pediatric infectious disease journal 23 (2), 138-144, 2004 | 204 | 2004 |
| Northern California Kaiser Permanente Vaccine Study Center Group. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children S Black, H Shinefield, B Fireman, E Lewis, P Ray, JR Hansen, L Elvin, ... Pediatr Infect Dis J 19 (3), 187-195, 2000 | 199 | 2000 |
| Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation SM Marcy, KS Kohl, R Dagan, D Nalin, M Blum, MC Jones, J Hansen, ... Vaccine 22 (5-6), 551-6, 2004 | 186 | 2004 |
| Safety of quadrivalent human papillomavirus vaccine administered routinely to females NP Klein, J Hansen, C Chao, C Velicer, M Emery, J Slezak, N Lewis, ... Archives of pediatrics & adolescent medicine 166 (12), 1140-1148, 2012 | 172 | 2012 |
| Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies NP Klein, P Ray, D Carpenter, J Hansen, E Lewis, B Fireman, S Black, ... Vaccine 28 (4), 1062-1068, 2010 | 145 | 2010 |
| Early estimates of bivalent mRNA vaccine effectiveness in preventing COVID-19–associated emergency department or urgent care encounters and hospitalizations among … MW Tenforde MMWR. Morbidity and mortality weekly report 71, 2022 | 131 | 2022 |
| Postmarketing evaluation of the safety and effectiveness of varicella vaccine S BLACK, H SHINEFIELD, P RAY, E LEWIS, J HANSEN, J SCHWALBE, ... The Pediatric infectious disease journal 18 (12), 1041-1046, 1999 | 124 | 1999 |
| Surveillance for invasive pneumococcal disease during 2000–2005 in a population of children who received 7-valent pneumococcal conjugate vaccine S Black, EK France, D Isaacman, L Bracken, E Lewis, J Hansen, ... The Pediatric infectious disease journal 26 (9), 771-777, 2007 | 110 | 2007 |
| Fever after immunization: current concepts and improved future scientific understanding KS Kohl, SM Marcy, M Blum, MC Jones, R Dagan, J Hansen, D Nalin, ... Clinical Infectious Diseases 39 (3), 389-394, 2004 | 104 | 2004 |
| Long-term effectiveness of the live zoster vaccine in preventing shingles: a cohort study R Baxter, J Bartlett, B Fireman, M Marks, J Hansen, E Lewis, L Aukes, ... American journal of epidemiology 187 (1), 161-169, 2018 | 86 | 2018 |
| Impact of the use of heptavalent pneumococcal conjugate vaccine on disease epidemiology in children and adults S Black, H Shinefield, R Baxter, R Austrian, L Elvin, J Hansen, E Lewis, ... Vaccine 24, S79-S80, 2006 | 65 | 2006 |
